glp 1 australia cost Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis | Diabetologia Weight loss drug Wegovy to

Estimates show that the typical employer could experience around a 50% increase in drug spend if half of the employees eligible for Wegovy were to take the drug

Mike Haney: I want to come back to all of those other potential benefits what that means for again that question of who are these for but just to, I'm curious, as I've watched this: we talk about sort of harnessing the satiating hormones

In October, Eli Lillys Zepbound and Mounjaro were removed from the drug shortage list after nearly two years, though the FDA warned that there still may be intermittent localized supply disruptions. The removal from the listwhich bars outsourcing facilities from producing compounded versionsspurred the Outsourcing Facilities Association to file a lawsuit against the FDA, saying the move will deprive much of the public of access to a needed medicine. In response, the FDA agreed to reevaluate the situation and will allow compounding to continue during this period

Cochrane Database Syst Rev 2021;4:CD004407